title: Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Fasano
authors.forename: Arianna
authors.initials: A
authors.lastname: Guidubaldi
authors.forename: Francesca
authors.initials: F
authors.lastname: De Nigris
authors.forename: Anna Rita
authors.initials: AR
authors.lastname: Bentivoglio
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D011446:Prospective Studies; D013764:Tetrahydronaphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring
chemical_list: D018491:Dopamine Agonists; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine